Clinical Trials
12
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
A Study of Intravenous L-Citrulline in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive Crisis
- First Posted Date
- 2025-05-25
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- Asklepion Pharmaceuticals, LLC
- Target Recruit Count
- 120
- Registration Number
- NCT06989567
- Locations
- 🇺🇸
Children's National Hospital, Washington, District of Columbia, United States
🇺🇸University of Miami, Coral Gables, Florida, United States
🇺🇸Emory University, Atlanta, Georgia, United States
A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects
- Conditions
- Ventricular Septal DefectAtrioventricular Septal DefectPrimum Atrial Septal Defect
- Interventions
- First Posted Date
- 2022-02-23
- Last Posted Date
- 2023-08-21
- Lead Sponsor
- Asklepion Pharmaceuticals, LLC
- Target Recruit Count
- 97
- Registration Number
- NCT05253209
- Locations
- 🇺🇸
Children's of Alabama, Birmingham, Alabama, United States
🇺🇸Children's Hospital of Colorado, Aurora, Colorado, United States
🇺🇸Heart Center, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
L-citrulline Injection in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting With Vaso-Occlusive Crisis (VOC)
- Conditions
- Acute Vaso Occlusive Crisis (VOC)
- Interventions
- Other: D5 1/2NS
- First Posted Date
- 2021-04-21
- Last Posted Date
- 2023-08-21
- Lead Sponsor
- Asklepion Pharmaceuticals, LLC
- Target Recruit Count
- 120
- Registration Number
- NCT04852172
- Locations
- 🇺🇸
Children's National Hospital, Washington DC, District of Columbia, United States
🇺🇸The University of Mississippi Medical Center, Jackson, Mississippi, United States
Intravenous L-Citrulline Influence on the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19
- Conditions
- Acute Hypoxemic Respiratory Failure
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-09-30
- Last Posted Date
- 2023-02-22
- Lead Sponsor
- Asklepion Pharmaceuticals, LLC
- Target Recruit Count
- 65
- Registration Number
- NCT04570384
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
L-citrulline for Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass for Heart Defects
- First Posted Date
- 2016-09-08
- Last Posted Date
- 2023-02-23
- Lead Sponsor
- Asklepion Pharmaceuticals, LLC
- Target Recruit Count
- 189
- Registration Number
- NCT02891837
- Locations
- 🇺🇸
University of Alabama, Birmingham, Alabama, United States
🇺🇸Loma Linda University Children's Hospital, Loma Linda, California, United States
🇺🇸University of California Davis Medical Center, Sacramento, California, United States
- Prev
- 1
- 2
- Next